SCHEMBL3898403

SCHEMBL3898403

Nc1ccc2c(c1Cl)C(=O)c1cscc1-2

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.69
▸ POLB P06746 4/20 0.69
▸ KMT2A Q03164 4/20 0.69
▸ THRB P10828 3/20 0.69
▸ ALDH1A1 P00352 3/20 0.69
▸ MAPT P10636 3/20 0.69
▸ BLM P54132 2/20 0.69
▸ MCL1 Q07820 2/20 0.69
▸ TDP1 Q9NUW8 2/20 0.69
▸ L3MBTL1 Q9Y468 2/20 0.69
▸ RAB9A P51151 2/20 0.69
▸ NPC1 O15118 1/20 0.69
▸ APEX1 P27695 1/20 0.69
▸ RECQL P46063 1/20 0.69
▸ ADORA2A P29274 4/20 0.40
▸ MAOA P21397 2/20 0.38
▸ CSNK1A1 P48729 2/20 0.38
▸ CSNK1D P48730 2/20 0.38
▸ CSNK1G1 Q9HCP0 2/20 0.38
▸ FGR P09769 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11370364 0.82 MEN1 (1.00) MEN1POLBKMT2ATHRBALDH1A1
SCHEMBL3897401 0.79 ALDH1A1 (0.40) MEN1POLBKMT2ATHRBALDH1A1
SCHEMBL3902622 0.79 MEN1 (0.44) MEN1POLBKMT2ATHRBALDH1A1
SCHEMBL3904075 0.79 ALDH1A1 (0.40) MEN1POLBKMT2ATHRBALDH1A1
SCHEMBL3902071 0.75 ADORA2A (0.61) MEN1POLBKMT2ATHRBALDH1A1
SCHEMBL3900138 0.75 MAPT (0.41) MEN1POLBKMT2ATHRBALDH1A1
SCHEMBL3902705 0.74 ADORA2A (0.60) MEN1POLBKMT2ATHRBALDH1A1
SCHEMBL8777863 0.74 ALDH1A1 (0.81) MEN1POLBKMT2ATHRBALDH1A1
SCHEMBL3902089 0.73 ALDH1A1 (0.37) MEN1POLBKMT2ATHRBALDH1A1
SCHEMBL3900430 0.72 THRB (0.35) MEN1POLBKMT2ATHRBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1383463-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE KING PHARMACEUTICALS INC (US) 2009-03-25 — — EP claimed
EP-1383463-A2 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE King Pharmaceuticals, Inc. (US) 2004-01-28 — — EP claimed
WO-2002083083-A2 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE KING PHARMACEUTICALS, INC. (US) 2002-10-24 — — WO claimed
EP-1383463-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE KING PHARMACEUTICALS INC (US) 2009-03-25 — — EP disclosed
EP-1383463-A2 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE King Pharmaceuticals, Inc. (US) 2004-01-28 — — EP disclosed
WO-2002083083-A2 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE KING PHARMACEUTICALS, INC. (US) 2002-10-24 — — WO disclosed
Send feedback